These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9138806)

  • 1. [Current treatment methods in myelodysplastic syndromes].
    Klimenko VI; Liubarets TF
    Lik Sprava; 1996; (10-12):20-6. PubMed ID: 9138806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [9th Antonio Raichs memorial lecture. Myelodysplastic syndromes].
    Giralt M
    Sangre (Barc); 1997 Feb; 42(1):63-71. PubMed ID: 9229805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth factors in haematology: prophylactic versus interventional use.
    Boogaerts MA
    Eur J Cancer; 1994; 30A(2):238-43. PubMed ID: 7908820
    [No Abstract]   [Full Text] [Related]  

  • 5. [What are the treatment possibilities for myelodysplastic syndrome?].
    von Wichert P
    Internist (Berl); 1995 Jan; 36(1):74-5. PubMed ID: 7883535
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute myelogenous leukemia and myelodysplastic syndromes.
    Estey EH
    Semin Hematol; 1995 Apr; 32(2):132-51. PubMed ID: 7652581
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of erythropoietin and other growth factors in transfusion medicine.
    Klingemann HG; Shepherd JD; Eaves CJ; Eaves AC
    Transfus Med Rev; 1991 Jan; 5(1):33-47. PubMed ID: 1802275
    [No Abstract]   [Full Text] [Related]  

  • 9. Myelodysplastic syndromes: a review for nurses.
    Cain J; Hood-Barnes J; Spangler J
    Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplasia: clinical and morphological aspects and treatment.
    Geary CG
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hematopoietic growth factors].
    Fillet G
    Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic growth factors in hematological malignancies.
    Kumar R; Rao RR; Ranjan S
    J Assoc Physicians India; 1995; Suppl 3():5-10. PubMed ID: 8773114
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of myelodysplastic syndromes.
    Hirst WJ; Mufti GJ
    Br J Haematol; 1993 Jun; 84(2):191-6. PubMed ID: 8398817
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 17. [The application of hematopoietic growth factors in oncology].
    Hoekman K; Wagstaff J; Ossenkoppele GJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):409-14. PubMed ID: 2020312
    [No Abstract]   [Full Text] [Related]  

  • 18. How to treat MDS without stem cell transplantation.
    Gattermann N
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S30-6. PubMed ID: 19857591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment options for myelodysplastic syndromes].
    Nolte F; Hofmann WK
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
    Cazzola M
    Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.